Both mutations and the overexpression of beta-catenin are allied with different cancers, including ovarian and endometrial carcinomas, hepatocellular carcinoma, colorectal carcinoma, malignant breast tumors, and lung cancer [51]. This evidence concerns the gene CTNNB1 and colorectal carcinoma.